Brian J Werth

11PUBLICATIONS
21CO-AUTHORS
Medical bacteriologyMedical virologyMedical infection agents (incl. prions)Aircraft performance and flight control systemsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 09, 2026
Synergy between orally bioavailable antibiotics and dalbavancin against MRSA.

|Jun 10, 2026
In vitro susceptibility of Stenotrophomonas maltophilia and other carbapenem non-susceptible Gram-negative rods in the Pacific Northwest to cefiderocol and aztreonam-avibactam.

|Mar 13, 2026
Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil.

Erica J Stohs, Bryan T Alexander, Paul D Fey

|Feb 12, 2025
Simulated exposures of oritavancin in in vitro pharmacodynamic models select for methicillin-resistant Staphylococcus aureus with reduced susceptibility to oritavancin but minimal cross-resistance or seesaw effect with other antimicrobials.

Brian J Werth, Rutan Zhang, Ismael A Barreras Beltran

|Nov 28, 2023
Elucidating the impact of bacterial lipases, human serum albumin, and FASII inhibition on the utilization of exogenous fatty acids by Staphylococcus aureus.

Emily L Pruitt, Rutan Zhang, Dylan H Ross

|Jun 15, 2022
Reporting behaviors and perceptions toward the National Healthcare Safety Network antimicrobial use (AU) and antimicrobial resistance (AR) modules.

Brian J Werth, Thomas J Dilworth, Zahra Kassamali Escobar

Pageof 2

Frequent Collaborators

4 joint publications

Libin Xu

2 joint publications

Stephen J Salipante

2 joint publications

Adam Waalkes

2 joint publications

Kelsi Penewit